Rationale for pertussis booster vaccination throughout life in Europe
Top Cited Papers
- 19 May 2011
- journal article
- review article
- Published by Elsevier
- Vol. 11 (7) , 557-570
- https://doi.org/10.1016/s1473-3099(11)70007-x
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Estimating the Duration of Pertussis Immunity Using Epidemiological SignaturesPLoS Pathogens, 2009
- Proficiency Program for Real-Time PCR Diagnosis of Bordetella pertussis Infections in French Hospital Laboratories and at the French National Reference Center for Whooping Cough and other BordetellosesJournal of Clinical Microbiology, 2009
- The epidemiology of pertussis in Germany: past and presentBMC Infectious Diseases, 2009
- What is new in pertussis?European Journal of Pediatrics, 2007
- Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategiesEpidemiology and Infection, 2007
- Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practiceBMC Infectious Diseases, 2007
- Multitarget PCR for Diagnosis of Pertussis and Its Clinical ImplicationsJournal of Clinical Microbiology, 2007
- Safety of reduced-antigen-content tetanus–diphtheria–acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis–containing vaccineThe Journal of Pediatrics, 2006
- Combined reduced-antigen-content diphtheria–tetanus–acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adultsVaccine, 2005
- High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccineVaccine, 2004